AP1485A
Orally administered controlled delivery system for once daily administration of ciprofloxacin.
Abstract
A once daily tablet formulation for oral administration in humans for the controlled release of ciprofloxacin comprising a pharmaceutically effective amount of ciprofloxacin, from about 0.1% to about 8.0% of a viscolyzing agent and/or a gelling agent, about 5.0% to about 15% of a gas generating agent, and about 3.0% to about 15% of a swelling agent, said percentages being w/w of the composition.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO0012198A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| EP0669129A2 | Cites | European Patent Office (EPO) | Search report |
| US5292518A | Cites | United States of America | Search report |
32 members in 25 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 51788700 | United States of America | A | |
| 51788700 | United States of America | A | |
| 0100279 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 0100279 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 09517887 | – | – | – |
| PCTTB0100279 | – | – | – |
| US20000517887 | – | – | – |
| WO2001IB00279 | – | – | – |
Members32
| Document | Office | Kind | |
|---|---|---|---|
| AP2001002084A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| CA2400950A1 | Canada | A1 | |
| WO0164183A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3589701A | Australia | A | |
| IS6532A | Iceland | A | |
| NO20024108D0 | Norway | D0 | |
| AP2002002627A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| NO20024108L | Norway | L | |
| EP1263409A1 | European Patent Office (EPO) | A1 | |
| KR20030009374A | Republic of Korea | A | |
| MXPA02008568A | Mexico | A | |
| EA200200914A1 | Eurasian Patent Organization (EAPO) | A1 | |
| IL151553A0 | Israel | A0 | |
| CZ20022883A3 | Czechia | A3 | |
| SK12542002A3 | Slovakia | A3 | |
| CN1420763A | China | A | |
| HU0204417A2 | Hungary | A2 | |
| HUP0204417A2 | Hungary | A2 | |
| ZA200206764B | South Africa | B | |
| BG107055A | Bulgaria | A | |
| NZ520927A | New Zealand | A | |
| JP2003525229A | Japan | A | |
| BR0108958A | Brazil | A | |
| AR032614A1 | Argentina | A1 | |
| EE200200497A | Estonia | A | |
| OA12381A | African Intellectual Property Organization (OAPI) | A | |
| PL365071A1 | Poland | A1 | |
| HRP20020715A2 | Croatia | A2 | |
| HU0204417A3 | Hungary | A3 | |
| HUP0204417A3 | Hungary | A3 | |
| AP1485AThis record | African Regional Intellectual Property Organization (ARIPO) | A | |
| AU2006201553A1 | Australia | A1 |
Numbers
- Publication
- AP 1485
- Publication, DOCDB
- 1485
- Publication, EPODOC
- AP1485
- Application
- 2002002627
- Application, DOCDB
- 2002002627
- Application, EPODOC
- AP20020002627
Titles
- English
- Orally administered controlled delivery system for once daily administration of ciprofloxacin.
Classification
- CPC, 3
- A61K9/0065
- A61K9/20
- A61P31/04
- IPC, 13
- A61K9 22
- A61K
- A61K9 00
- A61K9 20
- A61K9 52
- A61K31 495
- A61K31 496
- A61K31 506
- A61K47 04
- A61K47 32
- A61K47 36
- A61K47 38
- A61P31 04